Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Daily News

Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD

L.A. McKeown

November 04, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

Presentation TCT 2020

TCT 295: Outcomes With MANTA Device for Large-bore Access Closure After Transcatheter Aortic Valve Replacement

Presenter: Michael Megaly

October 14, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

Presentation TCT 2019

TCT 23: Heterogeneity of Debris Captured by Cerebral Embolic Protection Filters During Transcatheter Aortic Valve Replacement With Different Transcatheter Heart Valves

Presenter: Nicolas van Mieghem

September 25, 2019

Presentation TCT 2019

Transcatheter Aortic Valve Replacement in Complex Anatomy

Presenter: Futoshi Yamanaka, MD

September 25, 2019

Manuscript

Clinical and Economic Burden of Acute Ischemic Stroke Following Transcatheter Aortic Valve Replacement

December 11, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR

Todd Neale

October 22, 2018

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

News Daily News

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

L.A. McKeown

May 11, 2018

News Industry News

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

May 02, 2018

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

Caitlin E. Cox

February 05, 2018

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

Advertisement

New Faces, New Formats, New Tech: What to Expect From TCT 2022

September 2022 News Roundup

Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD

September 2021 News Roundup

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

TCT 295: Outcomes With MANTA Device for Large-bore Access Closure After Transcatheter Aortic Valve Replacement

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

TCT 23: Heterogeneity of Debris Captured by Cerebral Embolic Protection Filters During Transcatheter Aortic Valve Replacement With Different Transcatheter Heart Valves

Transcatheter Aortic Valve Replacement in Complex Anatomy

Clinical and Economic Burden of Acute Ischemic Stroke Following Transcatheter Aortic Valve Replacement

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

Next-Generation Large-Bore Closure Devices Arrive

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

TCTMD’s Top 10 Most Popular News and Features for 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content